Advertisement

Topics

Companies Related to "A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients." [Most Relevant Company Matches] RSS

14:30 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients." found in our extensive corporate database of over 50,000 company records.

Showing "Study Subcutaneous Mircera Treatment Anemia Dialysis Patients" Companies 1–25 of 6,500+

Extremely Relevant

Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...


EPOGEN® (Epoetin alfa)

EPOGEN® (Epoetin alfa), one of the first biologic human therapeutics, is approved for the treatment of anemia in patients with chronic kidney disease who are on dialysis.

DACOGEN

DACOGEN is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British (FAB) subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and i...


Relevant

Quantitative Medical Systems

Founded in 1976, QMS has pioneered development of innovative products for renal dialysis treatment and management.QMS founder John Sargent, Ph.D., is well known for developing techniques with Frank Gotch, M.D., for the kinetic modeling of urea and other solutes and drugs. Urea kinetic techniques guided The National Cooperative Dialysis Study (NCDS) from 1976 to 1982. They form the basis for the qu...

Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care is the world's largest, integrated provider of products and services for individuals with chronic kidney failure, a condition that affects more than 1,400,000 individuals worldwide. Through its network of approximately 2,045 dialysis clinics in North America, Europe, Latin America and Asia-Pacific, Fresenius Medical Care provides dialysis treatment to approximately 158,700 p...

Satellite Healthcare

Satellite Healthcare is an established leader in driving clinical excellence through joint ventures with nephrologists. Through its partners WellBound and Satellite Dialysis, Satellite Healthcare provides early patient wellness education, superior clinical support services and a complete range of dialysis therapy choices. This comprehensive offering allows Satellite Healthcare to advance the sta...

ACRO

Health outcomes aren't jeopardized when patients participate in randomized clinical trials of approved treatments, according to a new study. The results address misgivings some physicians have had about whether enrolling patients in a clinical trial might have a detrimental impact on their ability to receive individualized treatment. Conducted by a team led by Yale University's Dr. Cary P. Gross, ...

AMAG Pharmaceuticals, Inc.

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

Fresenius Medical Care North America

Fresenius Medical Care North America is a subsidiary of Fresenius Medical Care AG & Co. KGaA, the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1,770,000 individuals worldwide. Through its network of 2,553 dialysis clinics in North Ameri...

Akebia Therapeutics, Inc.

Akebia Therapeutics is a discovery and development company focused on anemia and vascular disorders. Akebia’s lead program, AKB-6548, an orally bioavailable HIF-prolyl hydroxylase (HIF-PH) inhibitor for patients with anemia, is in phase 2 clinical trials. AKB-6548 potentially promises to be a safer, less expensive, orally dosed pharmaceutical to stimu...

Ortho Biotech

In 1990, Ortho Biotech was established as the first biotechnology subsidiary of Johnson & Johnson.Today, our products and treatments combat some of the most serious diseases - such as cancer, HIV/AIDS, and chronic kidney disease. They also help restore the health and comfort of patients undergoing elective surgery, organ transplants, and chemotherapy.We are a leader in the worldwide treatment of a...

Aksys Healthcare Ltd.

Aksys, Ltd. was formed to provide hemodialysis products and services for patients suffering from renal failure. Aksys has developed an automated personal hemodialysis system (the "Aksys PHD® System"), which is designed to assist patients in performing hemodialysis in alternate care settings, such as the patient's home, on a more frequent basis than currently practiced. Aksys believes that its pro...

DaVita, Inc.

DaVita Inc., a Fortune 500® company, is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and con...

Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV). RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, is a selective URAT1 transporter inhibitor in Phase 2 clinical development. Our next-generation URAT1 inhib...

Xenetic Biosciences Inc.

Xenetic Biosciences is a biopharmaceutical company developing next-generation biologic drugs and novel oncology therapeutics. Xenetic's proprietary drug technology platforms include PolyXen® for creating next-generation biologic drugs by extending the efficacy, safety and half-life of biologic drugs, and OncoHist® for the development of novel oncolog...

Xenetic Biosciences, Inc.

Xenetic Biosciences is a biopharmaceutical company developing next-generation biologic drugs and novel oncology therapeutics. Xenetic's proprietary drug technology platforms include PolyXen® for creating next generation biologic drugs by extending the efficacy, safety and half-life of biologic drugs and OncoHist® for the development of novel oncology...

Ortho Biotech, L.P.

Ortho Biotech Products, L.P. is a leading biopharmaceutical company devoted to helping improve the lives of patients with cancer and with anemia due to multiple causes, including chronic kidney disease. Since it was founded in 1990, Ortho Biotech and its worldwide affiliates have earned a global reputation for researching, manufacturing and marketing innovative products that enhance patients'...

U.S. Renal Care, Inc.

Founded in 2000 by an experienced team of healthcare executives, U.S. Renal Care, Inc. works in partnership with nephrologists to develop, acquire, and operate outpatient treatment centers for persons suffering from chronic kidney failure, also known as End Stage Renal Disease. The company provides patients with their choice of a full range of quality in-center, acute or at-home hemodialysis and p...

Ortho Biotech Products, L.P.

Ortho Biotech Products, L.P. is a leading biopharmaceutical company devoted to helping improve the lives of patients with cancer and with anemia due to multiple causes, including chronic kidney disease. Since it was founded in 1990, Ortho Biotech and its worldwide affiliates have earned a global reputation for researching, manufacturing and marketing innovative products that enhance patients'...

Aetna and Fresenius Medical Care

Fresenius Medical Care (NYSE: FMS) is the world’s leading company devoted to patient-oriented renal therapy. Through more than 2,900 clinics in North America, Europe, Latin America, Asia-Pacific and Africa, we provide kidney dialysis treatments to approximately 228,000 patients worldwide. We are also the world's leading maker of dialysis products such...

Satellite Healthcare, Inc.

Satellite Healthcare, Inc. is one of the nation's first and leading providers of dialysis services and kidney disease care. With its affiliated services - Satellite WellBound, Satellite Dialysis and Satellite Research, Satellite Healthcare provides early patient wellness education, personalized clinical services and a complete range of dialysis therapy choices. This comprehensive offering allows S...

Liberty Dialysis

With more than 112 dialysis clinics, Liberty Dialysis is dedicated to providing outstanding care for patients with kidney disease, and a rewarding career experience for its caregivers. Liberty has a history of developing clinics in underserved communities in conjunction with local physicians and non-profit organizations. Liberty partners with local nephrol...

GENOVO Incorporated

Gene therapy using viral vectors for the treatment of cancer, anemia, hepatitis and diabetes.

Shape Pharmaceuticals, Inc.

Shape Pharmaceuticals, Inc. is developing SHP-141, a novel, topical, “soft-drug” HDAC inhibitor for the treatment of patients with cutaneous T cell lymphoma (CTCL) and psoriasis. Shape has an ongoing Phase 1b clinical study in CTCL patients and has completed a Phase 1b clinical study in psoriasis patients. The development of SHP-141 is being supp...


More From BioPortfolio on "A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients."

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks